Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine + paracetamol + phenylephrine versus paracetamol + phenylephrine for common cold
2021-002058-96Phase 3Terminated
- Sponsor
- Lek
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine, acetaminophen and phenylephrine in nasopharyngitis, influenza-like illness (ILI) and Viral Upper Respiratory Infection (2 arms), sponsored by Lek. Started Aug 2021; status: terminated.
02
Drugs
acetylcysteineacetaminophenphenylephrine
03
Conditions
nasopharyngitisinfluenza-like illness (ILI)Viral Upper Respiratory Infection
Beyond the preview
Go deeper on 2021-002058-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002058-96.